Overview Efficacy and Safety of XT-150 in Osteoarthritis of the Knee Status: Completed Trial end date: 2022-04-26 Target enrollment: Participant gender: Summary This is a Phase 2 safety and efficacy study of XT-150 in adult participants experiencing moderate to severe pain due to osteoarthritis of the knee. Phase: Phase 2 Details Lead Sponsor: Xalud Therapeutics, Inc.